Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study

计划入组 100 人 · 首次发布于 2025 年 12 月 26 日

Adia Med of Winter Park LLC Chronic Kidney Disease Research Study

计划入组 100 人 · 首次发布于 2026 年 5 月 7 日

Adia Med of Winter Park LLC Lower Back Pain Research Study

计划入组 100 人 · 首次发布于 2026 年 5 月 14 日

Filgrastim biosimilar(Pharmapark LLC)

Epoetin beta biosimilar(Pharmapark LLC)

Interferon alfa-2b biosimilar(Pharmapark LLC)

CARDIOKINE BIOPHARMA LLC

United States

Edwards Lifesciences LLC

United States

Paratek Pharma, LLC

United States

Prestige Biopharma Partners with Teva Israel for Trastuzumab Biosimilar Commercialization

Travere Therapeutics Pauses Enrollment in Phase 3 Homocystinuria Trial Due to Manufacturing Issues

MAIA Biotechnology's THIO Shows Promise in Phase II Lung Cancer Trial; Institutional Investment Increases